Vienna
Austria
70
2013-12-05
47
2015-02-10
These are the the leading inventors for applications assigned to Intercell AG:
Intercell AG based in Vienna, AT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
antigens I and II
#2 | 2013-10-24 β Patent 9,895,437 granted on 2018-02-20Aluminum compounds for use in therapeutics and vaccines
#3 | 2013-09-19PEPTIDES PROTECTIVE AGAINST E. FAECALIS, METHODS AND USES RELATING THERETO
#4 | 2013-09-05KLEBSIELLA ANTIGENS
#5 | 2013-08-22VACCINE COMPOSITION COMPRISING AN ANTIGEN AND A PEPTIDE HAVING ADJUVANT PROPERTIES
#6 | 2013-07-18 β Patent 8,945,591 granted on 2015-02-03Methods and compositions involving immunostimulatory oligodeoxynucleotides
#7 | 2013-07-16 β Patent 8,486,419 granted on 2013-07-16Attenuated live vaccine
#8 | 2013-05-30S. PNEUMONIAE ANTIGENS
#9 | 2013-05-16STREPTOCOCCUS PYOGENES ANTIGENS
#10 | 2013-05-16S. EPIDERMIDIS ANTIGENS
#11 | 2013-05-09BORRELIA ANTIGENS
#12 | 2013-05-02FULLY HUMAN INFLUENZA M2 SPECIFIC ANTIBODIES
#13 | 2013-04-25 β Patent 8,795,690 granted on 2014-08-05Protective proteins of , combinations thereof and methods of using the same
#14 | 2013-02-07 β Patent 8,715,688 granted on 2014-05-06Method for identification, isolation and production of antigens to a specific pathogen
#15 | 2013-01-10 β Patent 8,637,052 granted on 2014-01-28antigens
#16 | 2012-12-06 β Patent 8,765,148 granted on 2014-07-011C31 nanoparticles
#17 | 2012-11-22 β Patent 8,445,001 granted on 2013-05-21Peptides protective against and compositions, methods and uses relating thereto
#18 | 2012-10-25 β Patent 8,372,410 granted on 2013-02-12S. epidermidis antigens
#19 | 2012-07-19 β Patent 8,303,961 granted on 2012-11-06antigens
#20 | 2012-06-07MORAXELLA CATARRHALIS ANTIGENS
#21 | 2012-04-05 β Patent 8,431,128 granted on 2013-04-30antigens
#22 | 2012-02-23 β Patent 8,617,574 granted on 2013-12-31Nontypable antigens
#23 | 2011-12-08 β Patent 8,277,815 granted on 2012-10-02Pharmaceutical composition comprising an antigen
#24 | 2011-11-24 β Patent 8,318,908 granted on 2012-11-27Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof
#25 | 2011-11-03 β Patent 8,460,670 granted on 2013-06-11Fully human influenza M2 specific antibodies
#26 | 2011-10-06 β Patent 8,529,910 granted on 2013-09-10Enterococcus antigens
#27 | 2011-09-29Bacterial Polysaccharide-Polypeptide Conjugate Compositions
#28 | 2011-09-29 β Patent 8,236,326 granted on 2012-08-07antigens
#29 | 2011-06-30 β Patent 8,449,892 granted on 2013-05-28antigens I and II
#30 | 2011-04-21 β Patent 8,241,643 granted on 2012-08-14Peptides protective against and compositions, methods and uses relating thereto
#31 | 2011-01-27 β Patent 8,323,660 granted on 2012-12-04Method for identification, isolation and production of antigens to a specific pathogen
#32 | 2010-12-28 β Patent 7,858,588 granted on 2010-12-28Immunostimulatory oligodeoxynucleic molecules
#33 | 2010-12-23 β Patent 8,715,999 granted on 2014-05-06Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines
#34 | 2010-11-25 β Patent 8,236,325 granted on 2012-08-07antigens
#35 | 2010-10-14 β Patent 8,372,411 granted on 2013-02-12antigens
#36 | 2010-10-07 β Patent 8,349,336 granted on 2013-01-08antigens
#37 | 2010-08-12CHLAMYDIA ANTIGENS
#38 | 2010-07-01 β Patent 8,529,911 granted on 2013-09-10Small antigens and their use
#39 | 2010-06-03 β Patent 8,129,165 granted on 2012-03-06antigens
#40 | 2010-05-27 β Patent 8,343,510 granted on 2013-01-01Protective proteins of , combinations thereof and methods of using the same
#41 | 2010-05-06 β Patent 7,960,533 granted on 2011-06-14Nucleic acids coding for adhesion factor of group B , adhesion factors of group B and further uses thereof
#42 | 2010-02-25PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE AND COMPOSITIONS, METHODS AND USES RELATING THERETO
#43 | 2009-07-23HCV Vaccinations
#44 | 2009-03-05 β Patent 7,927,607 granted on 2011-04-19antigens I and II
#45 | 2009-03-05HCV Vaccines for Chronic HCV Patients
#46 | 2008-07-24Enterococcus Antigens
#47 | 2008-07-10 β Patent 7,658,928 granted on 2010-02-09Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptide
#48 | 2008-06-19Method for Solubilizing Peptide Mixtures
#49 | 2008-02-14 β Patent 7,771,728 granted on 2010-08-10Method for identification, isolation and production of antigens to a specific pathogen
#50 | 2007-12-13 β Patent 9,573,979 granted on 2017-02-21Modified VP1-capsid protein of parvovirus B19
#51 | 2007-07-17 β Patent 7,244,438 granted on 2007-07-17Uses for polycationic compounds
#52 | 2007-06-14 β Patent 7,528,223 granted on 2009-05-05Antigens encoded by alternative reading frames from pathogenic viruses
#53 | 2007-06-07Td antigens
#54 | 2007-02-22Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses
#55 | 2007-02-15 β Patent 7,628,994 granted on 2009-12-08antigens
#56 | 2007-02-08Hcv vaccines
#57 | 2006-12-12 β Patent 7,148,191 granted on 2006-12-12Antigenic composition
#58 | 2006-11-30 β Patent 7,438,912 granted on 2008-10-21antigens I + II
#59 | 2006-11-23 β Patent 7,635,487 granted on 2009-12-22antigens
#60 | 2006-11-23 β Patent 7,704,514 granted on 2010-04-27Vaccines
#61 | 2006-10-26Chlamydia pneumoniae antigens
#62 | 2006-09-28 β Patent 7,378,234 granted on 2008-05-27Method for isolating hepatitis C virus peptides
#63 | 2006-08-31 β Patent 7,638,136 granted on 2009-12-29Streptococcus pyogene antigens
#64 | 2006-08-31H pylori antigens
#65 | 2006-06-01 β Patent 7,485,710 granted on 2009-02-03Nucleic acids coding for adhesion factor of group B , adhesion factors of group B and further uses thereof
#66 | 2005-10-06Use of molecules which interact with the haptoglobin receptor ligand binding
#67 | 2005-03-31Method for stabilising of nucleic acids
#68 | 2005-03-24 β Patent 8,361,476 granted on 2013-01-29Vaccine composition comprising an antigen and a peptide having adjuvant properties
#69 | 2005-03-22 β Patent 6,869,607 granted on 2005-03-22Vaccine formulations
#70 | 2005-02-17 β Patent 7,968,297 granted on 2011-06-28Method for identification, isolation and production of antigens to a specific pathogen
Also check out Intercell AG's (Vienna, Austria) applicant profile with 2 patent applications submitted.
3338 β